Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone Loss with Concurrent PrEP and DMPA
NCT03464266Phase 4Completed
- Sponsor
- University of Washington
- Start
- May 2018
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of emtricitabine + tenofovir disoproxil, medroxyprogesterone acetate in human immunodeficiency virus infection (HIV), sponsored by University of Washington. Started May 2018; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxilmedroxyprogesterone acetate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03464266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03464266.